文献速递母胎医学产科

产前诊断的胼胝体发育不全:识别潜在的遗传病因

Prenatal Diagnosed Agenesis of the Corpus Callosum: Identifying the Underlying Genetic Etiologies.
PubMed 文献 · Prenat Diagn · 2024-08-08

该回顾性分析纳入2016年1月至2022年12月产前诊断胼胝体发育不全(ACC)并接受羊膜腔穿刺的68例胎儿,评估CMA、核型和ES的遗传病因检出率及妊娠结局。CMA检出致病性CNV 8例(11.8%,8/68),均为非孤立性ACC;26例CMA正常者中ES检出致病/可能致病变异12例(46.2%,12/26),孤立性与非孤立性ACC的ES检出率分别为40%(6/15)和54.5%(6/11)。12例活产中91.7%(11/12)神经发育正常,孤立性ACC且ES正常者均发育正常。

要点

  • 产前ES可提高ACC遗传病因检出率,孤立性与非孤立性ACC的ES检出率分别为40%(6/15)和54.5%(6/11)。
  • CMA检出致病性CNV 8例(11.8%,8/68),均为非孤立性ACC,其中6/8核型也可检出。
  • 孤立性ACC且ES正常者神经发育结局良好,12例活产中91.7%(11/12)发育正常。

核心结论

  • 产前ES有助于确定孤立性或非孤立性ACC的遗传病因,孤立性ACC且ES结果正常者神经发育结局良好。

研究设计与样本

  • 回顾性分析2016年1月至2022年12月前瞻性收集的产前ACC且行羊膜腔穿刺的病例,共纳入68例胎儿。
  • ACC根据有无超声异常分为非孤立性和孤立性,在遗传咨询后行染色体微阵列分析(CMA)、核型和外显子组测序(ES)。
  • 妊娠结局由小儿神经外科医生评估,并通过电话对父母进行随访。

主要发现

  • CMA检出8例致病性拷贝数变异(CNV),均为非孤立性ACC,检出率11.8%(8/68),其中6/8核型可检出。
  • 26例CMA正常者行ES,检出致病或可能致病变异12例(46.2%,12/26),涉及L1CMA、SMARCB1、PPP2R1A、ARID1B、USP34、CDC42、NFIA和DCC基因。
  • 孤立性ACC的ES检出率为40%(6/15),非孤立性ACC为54.5%(6/11)。
  • 排除56例终止妊娠后,12例活产年龄15个月至7岁,91.7%(11/12)神经发育正常。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the genetic etiologies underlying agenesis of the corpus callosum (ACC) and its pregnancy outcomes in the era of next-generation sequencing. METHODS: A retrospective analysis was conducted on prospectively collected prenatal ACC cases in which amniocentesis was performed between January 2016 and December 2022. ACC was divided into non-isolated and isolated according to the presence or absence of ultrasound abnormalities. Chromosomal microarray analysis (CMA), karyotyping and exome sequencing (ES) were performed after genetic counseling. Pregnancy outcomes were assessed by pediatric neurosurgeons and were followed up by telephone through their parents. RESULTS: Sixty-eight fetuses with ACC were enrolled in this study. CMA detected eight cases with pathogenic copy number variants (CNVs) and all were non-isolated ACC, with a detection rate of 11.8% (8/68). Among the CMA abnormalities, the majority (6/8) were detectable by karyotyping. ES was performed in 26 cases with normal CMA, revealing pathogenic or likely pathogenic gene variations in 12 cases (46.2%, 12/26), involving L1CMA, SMARCB1, PPP2R1A, ARID1B, USP34, CDC42, NFIA and DCC genes. The detection rates of ES in isolated and non-isolated ACC were 40% (6/15) and 54.5% (6/11), respectively. After excluding cases where pregnancy was terminated (56 cases), there were 12 live births, ranging in age from 15 months to 7 years. Of these, 91.7% (11 out of 12) demonstrated normal neurodevelopmental outcomes. Specifically, all five cases with isolated ACC and negative ES results exhibited normal neurodevelopment. The remaining six cases with favorable outcomes were all isolated ACC, among which ES identified variants of DCC and USP34 gene in one each case. The other four cases were CMA-negative and declined ES. CONCLUSIONS: We highlight the efficacy of prenatal ES in determining the genetic etiology of ACC, whether isolated or not. Favorable neurodevelopmental outcomes were observed when ACC was isolated and with normal ES results.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Wei X, Cai L, Zhang L, et al. Prenatal Diagnosed Agenesis of the Corpus Callosum: Identifying the Underlying Genetic Etiologies. Prenat Diagn. 2024. PMID: 39117575. doi:10.1002/pd.6641

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。